BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31772122)

  • 1. Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer.
    Tamminga M; de Wit S; van de Wauwer C; van den Bos H; Swennenhuis JF; Klinkenberg TJ; Hiltermann TJN; Andree KC; Spierings DCJ; Lansdorp PM; van den Berg A; Timens W; Terstappen LWMM; Groen HJM
    Clin Cancer Res; 2020 Apr; 26(7):1656-1666. PubMed ID: 31772122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study.
    Duan X; Zhu Y; Cui Y; Yang Z; Zhou S; Han Y; Yu D; Xiao N; Cao X; Li Y; Liu S; Wang Z; Zhang W; Feng L; Zhang K; Shou J; Liu Z; Xu S
    Thorac Cancer; 2019 Feb; 10(2):163-169. PubMed ID: 30511800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer.
    Hashimoto M; Tanaka F; Yoneda K; Takuwa T; Matsumoto S; Okumura Y; Kondo N; Tsubota N; Tsujimura T; Tabata C; Nakano T; Hasegawa S
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):775-83. PubMed ID: 24618055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer.
    Huang HB; Ge MJ
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):515-9. PubMed ID: 26030121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.
    Murlidhar V; Reddy RM; Fouladdel S; Zhao L; Ishikawa MK; Grabauskiene S; Zhang Z; Lin J; Chang AC; Carrott P; Lynch WR; Orringer MB; Kumar-Sinha C; Palanisamy N; Beer DG; Wicha MS; Ramnath N; Azizi E; Nagrath S
    Cancer Res; 2017 Sep; 77(18):5194-5206. PubMed ID: 28716896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
    Chemi F; Rothwell DG; McGranahan N; Gulati S; Abbosh C; Pearce SP; Zhou C; Wilson GA; Jamal-Hanjani M; Birkbak N; Pierce J; Kim CS; Ferdous S; Burt DJ; Slane-Tan D; Gomes F; Moore D; Shah R; Al Bakir M; Hiley C; Veeriah S; Summers Y; Crosbie P; Ward S; Mesquita B; Dynowski M; Biswas D; Tugwood J; Blackhall F; Miller C; Hackshaw A; Brady G; Swanton C; Dive C;
    Nat Med; 2019 Oct; 25(10):1534-1539. PubMed ID: 31591595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
    Bayarri-Lara C; Ortega FG; Cueto Ladrón de Guevara A; Puche JL; Ruiz Zafra J; de Miguel-Pérez D; Ramos AS; Giraldo-Ospina CF; Navajas Gómez JA; Delgado-Rodriguez M; Lorente JA; Serrano MJ
    PLoS One; 2016; 11(2):e0148659. PubMed ID: 26913536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
    Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
    Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
    PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
    Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
    Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer.
    Li J; Liao Y; Ran Y; Wang G; Wu W; Qiu Y; Liu J; Wen N; Jing T; Wang H; Zhang S
    BMC Pulm Med; 2020 Oct; 20(1):274. PubMed ID: 33081780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
    Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
    Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?
    Sawabata N; Funaki S; Hyakutake T; Shintani Y; Fujiwara A; Okumura M
    Surg Today; 2016 Dec; 46(12):1402-1409. PubMed ID: 26951195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
    Dong J; Zhu D; Tang X; Lu D; Qiu X; Li B; Lin D; Li L; Liu J; Zhou Q
    PLoS One; 2019; 14(7):e0220306. PubMed ID: 31348821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients.
    Okumura Y; Tanaka F; Yoneda K; Hashimoto M; Takuwa T; Kondo N; Hasegawa S
    Ann Thorac Surg; 2009 Jun; 87(6):1669-75. PubMed ID: 19463575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC.
    Crosbie PA; Shah R; Krysiak P; Zhou C; Morris K; Tugwood J; Booton R; Blackhall F; Dive C
    J Thorac Oncol; 2016 Oct; 11(10):1793-7. PubMed ID: 27468936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.
    Bian J; Yan K; Liu N; Xu X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2621-2630. PubMed ID: 32661602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
    Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
    Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
    Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.